View in EDS PDF Full Text

Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.

Saved in:
Bibliographic Details
Title: Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
Authors: Darwanto, Agus1,2, Hein, Anne-Mette3, Strauss, Sascha4, Yi Kong5, Sheridan, Andrew1, Richards, Dan5, Lader, Eric6, Ngowe, Monika1,7, Pelletier, Timothy1, Adams, Danielle1,8, Ricker, Austin1, Patel, Nishit1, Kühne, Andreas4, Hughes, Simon9, Shiffman, Dan5, Zimmermann, Dirk4, Kai te Kaat4, Rothmann, Thomas4 Thomas.rothmann@qiagen.com, Kong, Yi10 (AUTHOR), Te Kaat, Kai11 (AUTHOR)
Source: BMC Cancer. 5/22/2017, Vol. 17, p1-8. 8p. 2 Color Photographs, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:14712407
DOI:10.1186/s12885-017-3328-z